BlackRock Investment Management, LLC - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 54 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$147,000
-12.0%
12,606
+1.2%
0.00%
Q3 2016$167,000
-31.8%
12,459
+0.8%
0.00%
Q2 2016$245,000
+6025.0%
12,355
+4942.9%
0.00%
Q1 2016$4,0002450.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$14,118,0003.56%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$12,637,0002.99%
SPHERA FUNDS MANAGEMENT LTD. 385,301$3,044,0000.52%
Boxer Capital, LLC 138,331$1,093,0000.26%
DAFNA Capital Management LLC 35,977$284,0000.20%
SABBY MANAGEMENT, LLC 223,100$1,762,0000.12%
Hikari Power Ltd 60,992$482,0000.06%
Perceptive Advisors 157,679$1,245,0000.06%
Lombard Odier Asset Management (USA) Corp 90,000$711,0000.06%
TFS CAPITAL LLC 12,128$96,0000.04%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders